Should You Settle or Vote? A Board's Guide to Activist Demands

You're six weeks from your Annual General Meeting. An activist has nominated three directors and is demanding strategic changes. Your advisers are split: some recommend settlement, others say take it to a vote. The decision you make now will shape shareholder perception, board composition, and your strategic flexibility for years.

Here's how to navigate this choice under the SEC's current market-led framework.

The Decision You Are Facing

When an activist launches a campaign, you must decide whether to negotiate a settlement (adding their nominees or making operational changes) or proceed to a contested vote. This isn't a binary governance versus defiance question. It's a strategic calculation about shareholder support, campaign credibility, and the specific changes being demanded.

The regulatory backdrop has shifted. The SEC now refrains from substantive responses to most Rule 14a-8 exclusions and has proposed rescinding that rule entirely. Chairman Paul Atkins described this as letting market participants resolve disputes without the agency "calling balls and strikes." For traditional hedge fund activism, which targets board seats rather than shareholder proposals, this means you operate in an environment where the SEC sets disclosure rules but doesn't adjudicate merit.

Your decision framework must account for this: the SEC will enforce transparency requirements and police false statements under Rule 14a-9, but it won't weigh in on whether the activist's strategy is sound or their demands reasonable.

Key Factors That Affect Your Choice

Activist credibility and shareholder alignment. Does the activist have a realistic path to electoral success? During the first half of 2026, activists announced 155 campaigns at U.S. companies with market capitalization of at least $250 million, volume up 37% year over year. Yet only 34 campaigns ended in public settlements, and just six proceeded to a vote. Management elected all of its nominees at six out of eight contests (75%). Shareholders consistently chose the least possible change, even when proxy advisers recommended the activist slate.

If your investor base is stable, your performance defensible, and the activist's thesis speculative, a vote may favor you.

The universal proxy card dynamic. Since these rules took effect, shareholders vote for minimal disruption. They can mix and match nominees, and they typically do so to preserve continuity. If the activist is demanding a full slate replacement or control, history suggests shareholders will reject it. If they're seeking a single seat and you've refused engagement, that seat may be granted.

Material transparency obligations. The SEC's July 9, 2026 guidance on campaign-specific special purpose vehicles now requires disclosure of investors who financed the activist's stake. If the activist raised capital through an SPV to target your company specifically, those investors must be identified in Schedule 13D filings, and those who invested over $500 must be named as participants in Schedule 14A. Review these filings. If the activist's backers have conflicting interests, short positions in your debt, competitive business lines, or a history of quick exits, those facts belong in your proxy statement and shareholder communications.

The activist's public statements. Has the activist made inflammatory or misleading claims? The SEC retains enforcement authority under Rule 14a-9 for false and misleading proxy solicitations. If the activist has misrepresented your financials, distorted board actions, or made unsupported allegations, document these statements and consider requesting SEC staff intervention. The agency has issued fewer comment letters on activist rhetoric in recent years, but that doesn't eliminate your obligation to correct the record or the staff's authority to act.

Path A: Settle Before the Vote

Choose this path when:

• The activist has demonstrated electoral viability (institutional support, credible operational thesis, or prior wins at comparable companies)
• You can negotiate terms that limit board disruption (one or two seats rather than a full slate, standstill provisions, expense reimbursement caps)
• The demanded changes align with your existing strategic review or would likely emerge from shareholder feedback anyway
• A contested vote would distract management during a critical transaction or operational period

What this requires:

Negotiate standstill agreements that prevent the activist from launching another campaign for a defined period (typically 18 to 36 months). Require confidentiality around settlement discussions to avoid signaling weakness to other activists. If you're adding a dissident nominee, structure the appointment as a board expansion rather than replacing an incumbent, preserving institutional knowledge.

Document the settlement's strategic rationale in your next proxy statement. Shareholders who opposed the activist's demands will want assurance that you settled from strength, not capitulation.

Path B: Proceed to a Contested Vote

Choose this path when:

• Your performance is defensible and your investor base has expressed support for the current strategy
• The activist's thesis relies on speculative value creation (aggressive M&A, unsupported margin assumptions, or short-term financial engineering)
• Proxy advisers' voting recommendations are split or favor management
• The activist has made false or misleading statements that you can refute with disclosed facts

What this requires:

Prepare a proxy statement that addresses every material claim in the activist's solicitation. If the activist formed an SPV to fund the campaign, identify the investors and any conflicts of interest. If they've distorted your financial performance, include reconciliations to GAAP measures and context for one-time charges.

Engage directly with your top 20 shareholders before the vote. Understand their concerns and be prepared to make operational commitments (capital allocation changes, board refreshment timelines, or strategic reviews) that don't require adding the activist's nominees.

If the activist has violated Rule 14a-9 by making materially false statements, request that the SEC staff issue a comment letter or bring an enforcement action. The staff's September 2, 2026 interpretations clarified that Schedule 13G filers don't lose eligibility merely by discussing voting decisions with the issuer or seeking clarification of disclosures, use that latitude to understand how passive investors are evaluating the contest.

Path C: Informal Resolution Without Public Settlement

Choose this path when:

• The activist's demands are operationally sound but don't require board representation to implement
• You can deliver on the requested changes (divestitures, cost reductions, or governance enhancements) within your existing strategic plan
• A public settlement would signal vulnerability to other activists, but ignoring the campaign would alienate shareholders

What this requires:

Announce the operational changes or strategic actions through normal disclosure channels (earnings calls, investor presentations, or 8-K filings) without referencing the activist campaign. The activist may claim credit, but you avoid the standstill restrictions and board seat commitments that come with formal settlements.

This path works when the activist's thesis is directionally correct but their tactics are opportunistic. You implement the substance of their demands while denying them the leverage that comes from a board seat or public settlement announcement.

Summary Matrix

The SEC's market-led approach doesn't eliminate your disclosure obligations or the activist's accountability for false statements. It does mean you must build your case on shareholder alignment and operational credibility, not regulatory intervention. Choose the path that strengthens both.